Poly Medicure Ltd - 531768 - Shareholding for the Period Ended March 31, 2021
Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here19-04-2021
19-04-2021
Poly Medicure Ltd - 531768 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Avinash ChandraDesignation :- Company Secretary and Compliance Officer14-04-2021
Poly Medicure Ltd - 531768 - Closure of Trading Window
Dear Sir/Madam, It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref no: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Thursday, the 1st April, 2021 till the end of 48 hours after the declaration of Financial Results for the quarter and year ended on 31st March, 2021. The date of the Board Meeting to consider the above financial results would be intimated to the Stock Exchange in due course. You are hereby requested to please take the above information on your records. Thanking You,31-03-2021
POLY MEDICURE LTD. - 531768 - Shareholding for the Period Ended February 19, 2021
Poly Medicure Ltd has submitted to BSE the Shareholding Pattern for the Period Ended February 19, 2021. For more details, kindly Click here22-02-2021
Poly Medicure gains 6% on successful fund raising via QIP issue
The company's QIP committee approved the allotment of 7.63 million equity shares to eligible qualified institutional buyers at a price of Rs 524 per equity share19-02-2021
POLY MEDICURE LTD. - 531768 - Outcome Of The Meeting Of The QIP Committee
Please note that the QIP Committee at its meeting held today, i.e., February 19, 2021, approved allotment of 76,33,587 Equity Shares of face value ? 5 each to eligible qualified institutional buyers at the issue price of ? 524 per Equity Share, i.e., at a premium of ? 519 per Equity Share, aggregating to ? 400 crore, pursuant to the Issue. Pursuant to the allotment of Equity Shares in the Issue, the paid-up equity share capital of the Company stands increased from ? 44,12,34,900 consisting of 8,82,46,980 Equity Shares to ? 47,94,02,835 consisting of 9,58,80,567 Equity Shares. The Issue opened on February 15, 2021 and closed on February 18, 2021 and the same was intimated to you through our letters dated February 15, 2021 and February 18, 2021, respectively.19-02-2021
POLY MEDICURE LTD. - 531768 - Outcome Of The Meeting Of The QIP Committee
We wish to inform you that in respect of the QIP, the QIP Committee of the Company has, at its meeting held today approved and adopted the placement document dated February 18, 2021 in connection with the QIP. The QIP Committee's meeting commenced at 10.00 p.m. and the meeting was concluded at 10.30 p.m. The QIP was opened on February 15, 2021 and closed today i.e. on February 18, 2021 and the same was intimated to you pursuant to our letters dated February 15, 2021 and February 18, 2021, respectively. We request you to take the above on record pursuant to compliance under Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.18-02-2021
POLY MEDICURE LTD. - 531768 - Outcome Of The Meeting Of The QIP Committee
Further to our letter dated February 15, 2021 intimating you about the meeting of the QIP Committee in respect of the Issue to be held on February 18, 2021. We wish to inform you that the QIP Committee at its meeting held today, i.e., February 18, 2021 has, inter alia, passed the following resolutions: a. approved closure of the QIP today, i.e., February 18, 2021; b. approved the issue price for 76,33,587 Equity Shares to be allotted to eligible qualified institutional buyers at a price of ? 524 per Equity Share, including a premium of ? 519 per Equity Share, which is at a discount of ? 26.79 (4.86% to the floor price of ? 550.79 per Equity Share), as permitted in terms of Regulation 176(1) of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the 'SEBI ICDR Regulations').18-02-2021
POLY MEDICURE LTD. - 531768 - Outcome Of The Meeting Of The QIP Committee
Dear Sir, Further to our letter dated February 15, 2021 intimating you about the meeting of the QIP Committee in respect of the Issue to be held on February 18, 2021. We wish to inform you that the QIP Committee at its meeting held today, i.e., February 18, 2021 has, inter alia, passed the following resolutions: a. approved closure of the QIP today, i.e., February 18, 2021; b. approved the issue price for 76,33,587 Equity Shares to be allotted to eligible qualified institutional buyers at a price of ? 524 per Equity Share, including a premium of ? 519 per Equity Share, which is at a discount of ? 26.79 (4.86% to the floor price of ? 550.79 per Equity Share), as permitted in terms of Regulation 176(1) of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the 'SEBI ICDR Regulations18-02-2021
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Meeting Updates
We wish to inform you that pursuant to the approval accorded by the board of directors of the Company (the 'Board'), at its meeting held on December 8, 2020 and special resolution passed by the members of the Company by way of postal ballot on January 14, 2021, the QIP Committee has, at its meeting held today, i.e., February 15, 2021, inter-alia, considered and approved the following resolutions (a) approval and adoption of the preliminary placement document dated February 15, 2021 and the application form in connection with the Issue; and (b) authorisation of the opening of the Issue today, i.e., February 15, 2021.15-02-2021